Disponible en / Available in:
Español
The organization of the event Strokes against Cystic Fibrosis in Mallorca would not be possible without the support of strong companies. In this edition, Linde joins Respiralia 2022 as a sponsor.
Linde, a leading company in the home respiratory therapy industry
Linde Healthcare offers all therapeutic services for the treatment of respiratory diseases, which improve ventilatory support and control alterations in the oxygenation of the organism.
The main home respiratory therapies are:
- Oxygen therapy, for chronic respiratory insufficiency
- CPAP, for sleep apnea
- Aerosol therapy, for the administration of drugs in aerosol form by inhalation
- Mechanical ventilation, to replace or mechanically assist pulmonary ventilation when a person is unable to breathe on his or her own.
Linde next to Respiralia
Linde’s relationship with the Respiralia Group goes way back, when it offered these services under the name of Carburos Médica. Since then, it has been more than 18 years of collaboration with the fight against Cystic Fibrosis through annual collaborations.
Many people already have a collection of swimming caps with the Linde logo in their homes, demonstrating the loyalty and solidarity of a company that is a world leader in its sector.
What is Cystic Fibrosis?
Cystic Fibrosis is a genetic, serious and degenerative disease that to date has no cure.
It mainly affects the respiratory, digestive, reproductive and sweat glands.
The treatment for Cystic Fibrosis includes antibiotherapy, a healthy and hypercaloric nutrition and respiratory physiotherapy combined with endurance exercises.
You can see the infographic published by the Cystic Fibrosis Spanish Federation in this link (Spanish version) or see how Dani tells us what this disease is for him in this vídeo (Spanish version).
Currently, more than 2000 mutations are known in the gene that is defective in people with Cystic Fibrosis, although only about 150 mutations are described as causing the disease.
Statistics show that 1 in 5,000 people in Spain has Cystic Fibrosis (1 in 6,400 in the Balearic Islands) and 1 in 35 people is a carrier of a gene that causes the disease (1 in 40 in the Balearic Islands).
In the Balearic Islands there are 76 known diagnosed cases, but statistics speak of between 85 and 90 possible cases.
The awareness project of the Respiralia Foundation aims to raise awareness of this disease in order to discover those cases of people who have Cystic Fibrosis but have not yet been diagnosed.
